CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunitz, O.
Right arrow Articles by Rossaint, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunitz, O.
Right arrow Articles by Rossaint, R.
Canadian Journal of Anesthesia 52:940-943 (2005)
© Canadian Anesthesiologists' Society, 2005

General Anesthesia

Xenon does not modify mivacurium induced neuromuscular block

[Le xénon ne modifie pas le bloc neuromusculaire induit par le mivacurium]

Oliver Kunitz, MD, Jan-Hinrich Baumert, MD, Klaus Hecker, MD, Mark Coburn, MD, Thorben Beeker, MD, André Zühlsdorff, MD, Jens Fassl, MD and Rolf Rossaint, MD

From the Department of Anaesthesiology, University Hospital of the RWTH Aachen, Aachen, Germany.

Address correspondence to: Dr. Oliver Kunitz, Department of Anesthesiology, University Hospital of the RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany. Phone: +49-241-8088179; Fax: +49-241-8082406; E-mail: oliver.kunitz{at}mutterhaus.de

Purpose: The interaction between mivacurium and inhaled anesthetics is known, with the exception of xenon. We compared the pharmacodynamics of mivacurium during xenon anesthesia vs total iv anesthesia with propofol.

Methods: This randomized controlled trial was carried out in the Aachen University Hospital. Forty-two adult patients ASA I or II, aged 18 to 60 yr, were randomized to receive either xenon or propofol anesthesia. Anesthesia was induced with propofol and remifentanil in both groups (each n = 21). The xenon group received xenon via facemask until an end-expiratory concentration of 60% was reached for one minute. Meanwhile, the acceleromyograph was calibrated and a train-of-four stimulation of the adductor pollicis muscle was started. After stabilization of the signal for five minutes, a single bolus of 0.16 mg·kg–1 mivacurium was injected. Anesthesia was maintained with xenon and remifentanil or with propofol and remifentanil.

Results: There were no significant differences between groups with respect to onset time (xenon 180 ± 64 vs propofol 195 ± 77 sec; P = 0.39), duration (xenon 16.18 ± 4.97 vs propofol 15.68 ± 6.17 min; P = 0.73), recovery index (xenon 5.63 ± 2.48 vs propofol 5.73 ± 2.12 min; P = 0.42) and clinical recovery (xenon 8.75 ± 2.57 vs propofol 9.28 ± 2.28 min; P = 0.22).

Conclusion: We conclude that the neuromuscular blocking effects of mivacurium are similar when given during propofol vs xenon anesthesia.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Coburn, O. Kunitz, C. C. Apfel, M. Hein, M. Fries, and R. Rossaint
Incidence of postoperative nausea and emetic episodes after xenon anaesthesia compared with propofol-based anaesthesia
Br. J. Anaesth., June 1, 2008; 100(6): 787 - 791.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Canadian Anesthesiologists' Society.